MedPath

The comparing the efficacy of Specific Cognitive Behavioral Protocol and Unified Protocol in reducing anxiety sensitivity, anxiety, depression and negative affect

Not Applicable
Conditions
Panic disorder [episodic paroxysmal anxiety] without agoraphobia
Major depressive disorder, recurrent, mild
Symptoms and signs involving emotional state
Condition 1: Panic disorder. Condition 2: Major depressive disorder. Condition 3: Emotional problems.
Registration Number
IRCT20180501039497N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
36
Inclusion Criteria

Being a student
Residence in the Zanjan city
Tending to participate in research

Exclusion Criteria

Drug abuse
Personality disorders
Cardiovascular diseases
More than two sessions of absenteeism during the intervention
Not attending in any of the evaluation sessions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety sensitivity. Timepoint: Pre-test, Post-test and follow up (two month after post-test). Method of measurement: Anxiety Sensitivity Index- 3 (ASI-III).
Secondary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Pre-test, Post-test and Follow up (Two month after post- test). Method of measurement: Beck Anxiety Inventory (BAI).;Depression. Timepoint: Pre-test, Post-test and Follow up (Two month after post-test). Method of measurement: Beck Depression Inventory-II (BDI-II).;Negative afect. Timepoint: Pre-test, Post-test and Follow up (Two month after post- test). Method of measurement: Positive and Negative Affect Schedule-Negative (PANAS-NA).
© Copyright 2025. All Rights Reserved by MedPath